Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,593 | 14,078 | 13,149 | 11,064 | 13,846 |
| Receivables | 46,418 | 45,435 | 43,522 | 39,838 | 38,837 |
| Income taxes - deferred | 1,968 | 1,968 | 1,875 | 1,875 | 1,800 |
| Other current assets | 8,610 | 6,343 | 5,532 | 6,186 | 3,976 |
| TOTAL | $111,654 | $74,903 | $71,712 | $65,435 | $65,275 |
| Non-Current Assets | |||||
| PPE Net | 852,553 | 843,942 | 796,958 | 740,888 | 649,719 |
| Investments And Advances | 47,260 | 31,591 | 29,375 | 11,236 | 8,293 |
| Intangibles | 2,130 | 2,333 | 2,604 | 3,000 | 3,320 |
| Other Non-Current Assets | 1,143 | 599 | 0 | 0 | 0 |
| TOTAL | $903,086 | $878,465 | $828,937 | $755,124 | $661,332 |
| Total Assets | $1,014,740 | $953,368 | $900,649 | $820,559 | $726,607 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 25,764 | 25,764 | 25,764 | 15,600 | 15,600 |
| Accounts payable and accrued liabilities | 28,924 | 36,950 | 75,508 | 98,553 | 147,247 |
| Accrued Expenses | 6,016 | 5,761 | 7,915 | 5,231 | 5,291 |
| TOTAL | $71,863 | $79,053 | $119,134 | $128,662 | $178,061 |
| Non-Current Liabilities | |||||
| Long Term Debt | 528,573 | 575,014 | 505,555 | 427,200 | 295,600 |
| Deferred Revenues | 7,391 | 6,786 | 6,703 | 5,799 | 6,066 |
| Other Non-Current Liabilities | 99,935 | -32 | -183 | -211 | -199 |
| TOTAL | $678,604 | $625,579 | $544,653 | $467,967 | $336,437 |
| Total Liabilities | $750,467 | $704,632 | $663,787 | $596,629 | $514,498 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,295 | 19,295 | 19,295 | 19,295 | 19,295 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 119,623 | 105,232 | 92,341 | 78,719 | 67,839 |
| Other shareholders' equity | 16,161 | 15,319 | 16,699 | 17,705 | 17,034 |
| TOTAL | $264,273 | $248,736 | $236,862 | $223,930 | $212,109 |
| Total Liabilities And Equity | $1,014,740 | $953,368 | $900,649 | $820,559 | $726,607 |